Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!

Mohamed S A Mohamed

DOI: 10.4274/tnd.65882

Issue: 2018, Volume 24 - Issue 1
0 313

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir

DOI: 10.4274/tnd.62144

Issue: 2017, Volume 23 - Issue 4
0 539

Quality of Life, Coping, and Social Support in Patients with Multiple Sclerosis: A Pilot Study

Oğuzhan Zengin, Ercüment Erbay, Buğra Yıldırım, Özgür Altındağ

DOI: 10.4274/tnd.37074

Issue: 2017, Volume 23 - Issue 4
0 567

Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Vuslat Yılmaz, Deniz Ak Tura, Canan Ulusoy, Duygu Özkan Yaşargün, Suzan Adın Çınar, Recai Türkoğlu

DOI: 10.4274/tnd.87523

Issue: 2017, Volume 23 - Issue 4
0 385

Acute Spinal Pseudoathetosis

Mehmet Fevzi Öztekin, Dilara Mermi Dibek

DOI: 10.4274/tnd.27167

Issue: 2017, Volume 23 - Issue 4
0 307

Weight Loss and Fingolimod

Nefati Kıylıoğlu

DOI: 10.4274/tnd.87528

Issue: 2017, Volume 23 - Issue 4
0 345

The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis

Şenay Yıldız Çelik

DOI: 10.4274/tnd.71354

Issue: 2017, Volume 23 - Issue 3
0 341

Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis

Ahmed Serkan Emekli

DOI: 10.4274/tnd.90018

Issue: 2017, Volume 23 - Issue 3
0 315

Evaluation of the Effects of Adipocytokines on Prognosis in Ischemic Cerebrovascular Events

Muzaffer Şükriye Aliye Türkeş Demir, Özge Arıcı Düz, Nihal Işık

DOI: 10.4274/tnd.02170

Issue: 2017, Volume 23 - Issue 2
0 394

The Predictive Role of NEDA in the Long-Term Course of Multiple Sclerosis

Özgü Kizek

DOI: 10.4274/tnd.65391

Issue: 2017, Volume 23 - Issue 1
0 355

Does Serum Vitamin D Level During Pregnancy Influence the Risk of Multiple Sclerosis?

Tuncay Gündüz

DOI: 10.4274/tnd.28566

Issue: 2016, Volume 22 - Issue 4
0 363

Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment

Serhan Sevim

DOI: 10.4274/tnd.75318

Issue: 2016, Volume 22 - Issue 3
0 558

Cognitive Impairment in Young Multiple Sclerosis and Essential Tremor Patients: A Comparative Study

Hakan Serdar Şengül, Yıldızhan Şengül, Selma Yücel, Hulki Forta

DOI: 10.4274/tnd.46704

Issue: 2016, Volume 22 - Issue 3
0 435

Investigation of Patients with Hippocampal Sclerosis Associated with Unusual Epileptic Activities

Ebru Nur Vanlı Yavuz, Hakan Yener, Zeynep Aydın Özemir, Nerses Bebek, Candan Gürses, Ayşen Gökyiğit, Betül Baykan

DOI: 10.4274/tnd.80037

Issue: 2016, Volume 22 - Issue 2
0 392

Etiologic Subtypes, Risk Factors And Outcome Of Acute Ischemic Stroke With Young Patients

İnci Şule Özer, Mine Hayriye Sorgun, Sefer Rzayev, Müge Kuzu, Sabiha Tezcan, Volkan Yılmaz, Çağrı Ulukan, Hafize Çotur, Anwar Rawandi, Canan Togay Işıkay

DOI: 10.4274/tnd.68725

Issue: 2015, Volume 21 - Issue 4
0 425

Isolated Complete Horizontal Gaze Palsy and Multiple Sclerosis

Hakan Tekeli, Mustafa Tansel Kendirli, Mehmet Güney Şenol, Rıfat Erdem Toğrol, Mehmet Fatih Özdağ, Serkan Demir

DOI: 10.4274/tnd.93899

Issue: 2015, Volume 21 - Issue 4
0 340

Process From Diagnosis To Treatment Of 3 SSPE Cases Presented At The Late Age

Aylin Bican, İbrahim Bora

DOI: 10.4274/tnd.03789

Issue: 2015, Volume 21 - Issue 3
0 388

A Case Followed as Having Multiple Sclerosis but Diagnosed with Secondary Brain Lymphoma

Serkan Demir, Rıfat Erdem Toğrol, Ali&775; Rıza Sonkaya, Tolga Tuncel

DOI: 10.4274/tnd.70845

Issue: 2015, Volume 21 - Issue 3
0 449

Prevalence Of Thrombophilic Mutations In Ischemic Stroke Patients In Isparta, Turkey

Nilgün Erten, Serpil Demirci, Recep Sütçü

DOI: 10.4274/tnd.37880

Issue: 2015, Volume 21 - Issue 2
0 449

Do steroids trigger mania in multiple sclerosis? Not always!

Serhan Sevim, Serhan Karakılıç, Ayşe Devrim Başterzi, Mefkure Eraksoy

DOI: 10.4274/tnd.91328

Issue: 2015, Volume 21 - Issue 2
0 620